Applied Therapeutics, Inc. (APLT) Earnings History
Net Loss8 years of earnings data (2017–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
Applied Therapeutics, Inc. (APLT) Earnings Overview
As of June 28, 2026, Applied Therapeutics, Inc. (APLT) reported trailing twelve-month net income of -$18M, reflecting +46.5% year-over-year growth. The company earned $-0.12 per diluted share over the past four quarters, with a net profit margin of -23214.1%.
Looking at the long-term picture, APLT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2017.
Applied Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including RARE (-$609M net income, -85.4% margin), FOLD (-$27M net income, -4.3% margin), ACAD ($376M net income, 36.5% margin), APLT has room to improve margins relative to the peer group. Compare APLT vs RARE →
APLT Earnings vs Peers
Earnings metrics vs comparable public companies
APLT Historical Earnings Data (2017–2024)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$106M | +11.8% | -$104M | $-0.76 | -23214.1% | -22922.9% |
| 2023 | -$120M | -45.2% | -$65M | $-1.42 | -1198.5% | -645.8% |
| 2022 | -$83M | +21.9% | -$83M | $-2.18 | - | - |
| 2021 | -$106M | -12.4% | -$106M | $-4.12 | - | - |
| 2020 | -$94M | -106.4% | -$94M | $-4.28 | - | - |
| 2019 | -$46M | -175.5% | -$46M | $-3.55 | - | - |
| 2018 | -$17M | -285.8% | -$14M | $-1.80 | - | - |
| 2017 | -$4M | - | -$4M | $-0.47 | - | - |
Download Data
Export APLT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
APLT — Frequently Asked Questions
Quick answers to the most common questions about buying APLT stock.
What is APLT earnings per share (EPS)?
APLT trailing twelve-month (TTM) diluted EPS is $-0.12, reflecting +46.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2017 to 2024 is available in the table on this page.
What is Applied Therapeutics, Inc.'s net income?
Applied Therapeutics, Inc. (APLT) trailing twelve-month net income is $-18M as of 2024. Earnings grew +46.5% year-over-year.
Is APLT profitable?
APLT is not currently profitable on a TTM basis, reporting a net loss of $-18M. Net margin is -23214.1%. Investors should monitor for a return to profitability.
What is APLT's earnings growth rate?
APLT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2024.
What are APLT's profit margins?
Applied Therapeutics, Inc. net profit margin is -23214.1%, operating margin is -22922.9%, and gross margin is -10613.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -530.0%.
Is APLT growing earnings?
Yes, APLT earnings are accelerating — EPS growth of +46.5% exceeds the 5-year CAGR of N/A. TTM net income reached $-18M. Earnings momentum is strengthening.
What was APLT's best earnings year?
Applied Therapeutics, Inc.'s highest annual net income on record is $-4M, achieved in fiscal year 2017. Earnings history on this page spans 2017 to 2024 and includes all annual and quarterly figures.
What were APLT's earnings last quarter?
APLT's most recent reported quarter was Q3 2025. Net income was $-19M with diluted EPS of $-0.13. For a full breakdown of all quarters, see the quarterly earnings table on this page.